mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors.
about
mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@en
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@nl
type
label
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@en
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@nl
prefLabel
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@en
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@nl
P2093
P2860
P1433
P1476
mTOR and HDAC Inhibitors Conve ...... gression of RAS-Driven Tumors.
@en
P2093
Chloe Emerson
Clare F Malone
Franziska Michor
Karen Cichowski
Kay F Macleod
Marcia Haigis
Ophélia Maertens
Rachel Ingraham
Stephanie Guerra
P2860
P304
P356
10.1158/2159-8290.CD-17-0177
P50
P577
2017-09-29T00:00:00Z